Sézary Syndrome
What is Sézary Syndrome?
Sézary syndrome is a rare and aggressive form of cutaneous T-cell lymphoma. This means it is a blood cancer that primarily affects the skin. Abnormal T-lymphocytes, a type of white blood cell that normally fights infection, become cancerous and circulate throughout the bloodstream. These malignant cells are called Sézary cells.
Unlike other skin conditions, Sézary syndrome affects the entire body surface. The cancerous T-cells accumulate in the skin, blood, and sometimes lymph nodes. This causes widespread skin changes that can be mistaken for eczema or psoriasis at first. However, Sézary syndrome is a leukemic variant of lymphoma, which means the cancer cells move freely through the blood.
Early detection through blood testing is critical for managing this condition. Sézary syndrome typically affects adults over age 60. Men develop this condition slightly more often than women. Because it involves the blood, regular monitoring of lymphocyte counts and cell morphology, or cell shape and structure, helps doctors track disease progression.
Symptoms
- Red, itchy, and scaly skin covering most or all of the body
- Thickened or peeling skin on the palms and soles
- Intense itching that interferes with sleep and daily activities
- Swollen lymph nodes in the neck, armpits, or groin
- Hair loss or thinning, particularly on the scalp
- Changes in fingernails and toenails, including thickening or lifting
- Enlarged spleen or liver
- Abnormal skin color changes, appearing darker or lighter in patches
Most people with Sézary syndrome experience severe symptoms that affect quality of life. The widespread skin involvement makes this condition difficult to ignore. However, early stages may be mistaken for chronic skin conditions like eczema, delaying proper diagnosis.
Concerned about Sézary Syndrome? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Sézary syndrome develops when T-lymphocytes, a type of immune cell, undergo abnormal changes and become cancerous. The exact trigger for this transformation remains unknown. Researchers believe it involves multiple genetic mutations that cause T-cells to multiply uncontrollably. These malignant cells then travel through the bloodstream and accumulate in the skin.
Risk factors include being over age 60 and male gender. However, the condition can affect anyone. There is no clear link to environmental toxins, infections, or lifestyle factors. Most cases appear spontaneously without a family history. Unlike some cancers, Sézary syndrome is not caused by sun exposure or other known skin damage. The condition is not contagious and cannot spread from person to person.
How it's diagnosed
Diagnosis requires multiple tests that examine the skin, blood, and sometimes lymph nodes. A skin biopsy allows doctors to look at tissue under a microscope for abnormal T-cells. Blood tests measure absolute lymphocyte count and identify Sézary cells circulating in the bloodstream. Finding these abnormal cells in the blood is a key diagnostic criterion.
Rite Aid offers blood testing that measures lymphocyte levels at over 2,000 Quest Diagnostics locations nationwide. Regular monitoring helps track disease activity and response to treatment. Additional specialized tests may examine cell surface markers to confirm the diagnosis. Doctors also check for enlarged lymph nodes or organs using imaging studies.
Treatment options
- Skin-directed therapies including topical medications, light therapy, and electron beam radiation
- Systemic medications such as chemotherapy, immunotherapy, and targeted therapies
- Extracorporeal photopheresis, which removes blood, treats it with light, and returns it to the body
- Biologic therapies that target specific proteins on cancer cells
- Stem cell transplant in select cases for younger patients
- Supportive care including moisturizers and antihistamines for itching
- Infection prevention and treatment, as the condition weakens the immune system
Treatment focuses on controlling symptoms and slowing disease progression. Most patients require ongoing therapy rather than a one-time cure. A dermatologist and hematologist, a blood cancer specialist, typically work together to manage care. Regular blood monitoring helps assess treatment response and adjust therapy as needed.
Concerned about Sézary Syndrome? Get tested at Rite Aid.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Both are types of cutaneous T-cell lymphoma, but Sézary syndrome is more aggressive and involves the blood from the start. Mycosis fungoides typically begins as skin patches that may progress slowly over years. Sézary syndrome presents with widespread skin involvement and abnormal lymphocytes circulating in the bloodstream. Some cases of mycosis fungoides can evolve into Sézary syndrome over time.
Doctors measure absolute lymphocyte count and look for Sézary cells under a microscope. These are abnormal T-lymphocytes with distinctive features including a folded nucleus. Blood tests also measure the percentage of abnormal cells compared to normal lymphocytes. A diagnosis typically requires finding elevated numbers of these malignant cells in multiple blood samples.
Most cases cannot be cured, but treatment can control symptoms and slow progression for months or years. Some patients achieve long-term remission with aggressive therapies including stem cell transplant. The goal of treatment is to reduce cancer cell burden and improve quality of life. Ongoing monitoring and adjusted therapies help manage the condition over time.
The malignant T-cells release chemicals called cytokines that trigger intense itching. These cells accumulate in the skin and activate nerve endings that sense itch. The widespread skin inflammation also contributes to discomfort. Managing itching is a major focus of treatment, as it significantly impacts sleep and daily function.
Testing frequency depends on disease stage and treatment phase. During active treatment, monthly blood tests help doctors monitor response and adjust therapies. Patients in remission may need testing every three to six months. Your care team will create a personalized monitoring schedule based on your individual situation.
Elevated lymphocyte counts suggest active disease with many abnormal cells circulating. Higher percentages of Sézary cells indicate more aggressive disease. Tracking these numbers over time shows whether treatment is working. Decreasing abnormal lymphocyte counts typically mean the cancer is responding to therapy.
The condition is not inherited and does not run in families. While genetic mutations cause the T-cells to become cancerous, these changes occur spontaneously during a person's lifetime. There is no known way to prevent these mutations from occurring. Family members of someone with Sézary syndrome do not have increased risk.
Prognosis varies widely based on disease burden, patient age, and response to treatment. Median survival ranges from two to five years after diagnosis. However, some patients live much longer with effective treatment. Factors like lower tumor burden and younger age at diagnosis are associated with better outcomes.
While lifestyle cannot cure the disease, certain habits support overall health during treatment. Gentle skin care with fragrance-free moisturizers helps manage dryness. Avoiding hot showers and harsh soaps reduces irritation. Maintaining good nutrition and staying physically active within your capacity supports immune function and treatment tolerance.
See a dermatologist for evaluation, especially if over-the-counter treatments fail. Widespread skin changes lasting more than a few weeks warrant medical attention. While most itchy skin conditions are not cancer, early diagnosis of Sézary syndrome improves treatment outcomes. Blood tests and skin biopsies help distinguish this condition from common skin disorders.